< Back to companies

Developer of a novel biomarker prognostic panel intended for the early prediction of preterm birth. The company uses data mining and multiple pathway analysis to identify asymptomatic women at risk of preterm birth, enabling clinicians to make informed decisions about interventions to prevent preterm birth.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2015
Website
www.carmentix.com/

Categories

Maternal HealthDiagnosticsPredictive Diagnostics
Only accessible to MedStartr community members. Join now

What do you think of Carmentix?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now